Announcements
Updated Journal Policies and Manuscript Template Adjustment
2025 Template Updates
- Journal Title : Pharmacology, Medical Reports, Orthopedic, and Illness Details
- Initials : COMORBID
- Frequency : January, April, July, October
- Online ISSN : 2809-9745
- Editor in Chief : Dr. Nicholas Chally Tirayoh
- Managing Editor : Dewi Anggraini
- DOI : 10.55047/comorbid by Crossref
- Publisher : Transpublika Publisher
- Contact WA : +62811231666
- E-mail : jurnalcomorbid@gmail.com
- Citation Analysis : Dimensions
Pharmacology, Medical Reports, Orthopedic, and Illness Details (COMORBID) is an open-access, double-blind, peer-reviewed journal that publishes research on all aspects of medicine, from fundamental research to major clinical trials and cost-effectiveness analyses. The COMORBID journal generally publishes human research that contributes to understanding of medical epidemiology, etiology, and physiology; the development of prognostic and diagnostic technologies; clinical trials that evaluate the efficacy of particular therapies, including comparative trials; and systematic reviews. It encourages the translation of fundamental research into clinical trials and of clinical evidence into therapeutic practice. Studies in animal models are published only occasionally, when their findings are remarkable and highly clinically relevant. The journal’s target audience includes the international medical community, educators, policymakers, patient advocacy groups, and other interested parties. The online edition of COMORBID is updated regularly.
Medical Informatics, Basic Science, Clinical Science, Case Report, Brief Communication, Public Health, Public Policy, and Review Articles from all branches of medicine and associated subjects are published in COMORBID journal. The journal is published periodically with the frequency of issuance 4 times a year (January, April, July, October)
e-ISSN 2809-9745 (online)
Pharmacology, Medical Reports, Orthopedic, and Illness Details (COMORBID) is an open-access, double-blind, peer-reviewed journal that publishes research on all aspects of medicine, from fundamental research to major clinical trials and cost-effectiveness analyses. The COMORBID journal generally publishes human research that contributes to understanding of medical epidemiology, etiology, and physiology; the development of prognostic and diagnostic technologies; clinical trials that evaluate the efficacy of particular therapies, including comparative trials; and systematic reviews. It encourages the translation of fundamental research into clinical trials and of clinical evidence into therapeutic practice. Studies in animal models are published only occasionally, when their findings are remarkable and highly clinically relevant. The journal’s target audience includes the international medical community, educators, policymakers, patient advocacy groups, and other interested parties. The online edition of COMORBID is updated regularly.
Medical Informatics, Basic Science, Clinical Science, Case Report, Brief Communication, Public Health, Public Policy, and Review Articles from all branches of medicine and associated subjects are published in COMORBID journal. The journal is published periodically with the frequency of issuance 4 times a year (January, April, July, October)
e-ISSN 2809-9745 (online)
Announcement of Updated Manuscript Template and Author Guidelines for Volume 6
2026-11-11Dear Authors, Reviewers, and Readers,
PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID) is pleased to announce an updated manuscript template, effective from Volume 6, Issue 1. This follows our earlier announcement on Updated Journal Policies, which aims to improve the quality of the journal.
2025 Template Updates
2024-11-02
Vol. 5 No. 3 (2026): JULY
Published: 2026-06-10
In this issue Vol. 5 No. 3 (2026): July, we have processed 8 submitted manuscripts. 2 articles were declined after initial review by the editor, 1 article was declined after the peer review process, and 5 articles were published.
In this issue Vol. 5 No. 3 (2026): July, all of the published articles were authored/co-authored by 26 authors, from 13 Institutions, and 3 Countries, i.e., Universitas Tarumanagara (Indonesia), K.R.M.T. Wongsonegoro Regional General Hospital (Indonesia), Universitas Airlangga (Indonesia), Dr. Soetomo General Academic Hospital (Indonesia), Universitas Maarif Hasyim Latif (Indonesia), National Hospital Abuja (Nigeria), Baze University Abuja (Nigeria), Federal University Lafia (Nigeria), Medical Laboratory Science Council of Nigeria (Nigeria), Plateau State University Bokkos (Nigeria), University of Jos (Nigeria), Cleveland Clinic (United States), and Federal University Wukari (Nigeria).










(

















